title: [Comparative characteristics of octreotide and famotidine in the treatment of acute pancreatitis].
abstract: Antisecretory therapy is an important and integral component of complex therapy of acute pancreatitis. The clinical estimation of efficiency of various antisecterory preparations, sandostatin and famotidin (quamatel) was made in treatment of acute pancreatitis at an early stage of the disease. The results of the research have shown that the efficiency of sandostatin and famotidin (quamatel) in treatment of not severe (mild and medium) forms of acute pancreatitis is approximately identical. But the application of famotidin (quamatel) is economically more favorable (8.3 times cheaper than sandostatin). In treatment of severe acute pancreatitis of paramount importance are the terms of the beginning of antisecretory therapy, the optimum term being the first day of the disease. The preparation of choice is sandostatin, the preparation of reserve--famotidin (quamotel). The duration of a medical course of treatment is the first three days from the beginning of the disease. The application of antisecretory preparations in question is less effective when used in later terms.
authors.forename: S F
authors.initials: SF
authors.lastname: Bagnenko
authors.forename: N V
authors.initials: NV
authors.lastname: Rukhliada
authors.forename: A D
authors.initials: AD
authors.lastname: Tolstoĭ
authors.forename: V R
authors.initials: VR
authors.lastname: Gol'tsov
authors.forename: V E
authors.initials: VE
authors.lastname: Nazarov
mesh_terms: D000208:Acute Disease; D015738:Famotidine / Q000008:administration & dosage / Q000627:therapeutic use*; D005765:Gastrointestinal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006635:Histamine H2 Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D015282:Octreotide / Q000008:administration & dosage / Q000627:therapeutic use*; D010195:Pancreatitis / Q000188:drug therapy*; D013997:Time Factors
chemical_list: D005765:Gastrointestinal Agents; D006635:Histamine H2 Antagonists; D015738:Famotidine; D015282:Octreotide